Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-23-024071

EVP, Chief Technology Officer sold 2,305 shares at $90.00 ($207,450)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lingamneni Anila EVP, Chief Technology Officer 2023-09-11 Sale 10b5-1 −2,305 $90.00 $207,450 14,495 D
Open-market sales · 2,305 sh · avg $90.00 · $207,450
Loading xslF345X05/form4.xml…